Juan M. Maler

Erlangen, BY 91054, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 39 publications

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy with non-hemorrhagic imaging marker.

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy with non-hemorrhagic imaging marker.

Journal: Alzheimer's & dementia (Amsterdam, Netherlands)

Published: October 31, 2025

Reduced serum AHR agonistic activity reflects amyloid dysregulation in AT1 subtypes of Alzheimer's disease.

Reduced serum AHR agonistic activity reflects amyloid dysregulation in AT1 subtypes of Alzheimer's disease.

Journal: Alzheimer's research & therapy

Published: June 11, 2025

Comparison of ERlangen Score with pTau/Aβ1-42 Ratio for Predicting Cognitive Decline and Conversion to Alzheimer's Disease.

Comparison of ERlangen Score with pTau/Aβ1-42 Ratio for Predicting Cognitive Decline and Conversion to Alzheimer's Disease.

Journal: Brain sciences

Published: February 10, 2025

Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.

Reconceptualization of the Erlangen Score for the Assessment of Dementia Risk: The ERlangen Score.

Journal: Journal of Alzheimer's disease : JAD

Published: September 24, 2023

Digit Ratio (2D:4D) Is Not Associated with Alzheimer's Disease in the Elderly.

Digit Ratio (2D:4D) Is Not Associated with Alzheimer's Disease in the Elderly.

Journal: Brain sciences

Published: July 24, 2023

PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts.

PASSED: Brain atrophy in non-demented individuals in a long-term longitudinal study from two independent cohorts.

Journal: Frontiers in aging neuroscience

Published: December 11, 2022

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.

Cerebrospinal fluid biomarkers for cerebral amyloid angiopathy.

Journal: Brain communications

Published: September 27, 2022

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy.

Amyloid-β levels and cognitive trajectories in non-demented pTau181-positive subjects without amyloidopathy.

Journal: Brain : a journal of neurology

Published: May 02, 2022

Cerebrospinal Fluid of Patients With Alzheimer's Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles.

Cerebrospinal Fluid of Patients With Alzheimer's Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles.

Journal: Frontiers in aging neuroscience

Published: March 17, 2021

The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes.

The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes.

Journal: Frontiers in molecular neuroscience

Published: October 09, 2020

DSC Brain Perfusion Using Advanced Deconvolution Models in the Diagnostic Work-up of Dementia and Mild Cognitive Impairment: A Semiquantitative Comparison with HMPAO-SPECT-Brain Perfusion.

DSC Brain Perfusion Using Advanced Deconvolution Models in the Diagnostic Work-up of Dementia and Mild Cognitive Impairment: A Semiquantitative Comparison with HMPAO-SPECT-Brain Perfusion.

Journal: Journal of clinical medicine

Published: May 05, 2020

Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines.

Pharmacological Inhibition of Amyloidogenic APP Processing and Knock-Down of APP in Primary Human Macrophages Impairs the Secretion of Cytokines.

Journal: Frontiers in immunology

Published: February 05, 2020

Showing 1-12 of 39

Last Updated: 09/26/2026